返回
Engineering splicing factors with designed specificities
DOI:10.1038/NMETH.1379.png)
摘要
En 中文
Alternative splicing is generally regulated by trans-acting factors that specifically bind pre-mRN A to activate or inhibit the splicing reaction. This regulation is critical for normal gene expression, and dysregulation of splicing is closely associated with human diseases. Here we engineered artificial splicing factors by combining sequence-specific RN A-binding domains of human Pumilio1 with functional domains that regulate splicing. We applied these factors to modulate different types of alternative splicing in selected targets, to examine the activity of effector domains from natural splicing factors and to modulate splicing of an endogenous human gene, Bcl-X, an anticancer target. The designer factor targeted to Bcl-X increased the amount of pro-apoptotic Bcl-xS splice isoform, thus promoting apoptosis and increasing chemosensitivity of cancer cells to common antitumor drugs. Our approach permitted the creation of artificial factors to target virtually any pre-mRN A, providing a strategy to study splicing regulation and to manipulate disease-associated splicing events.
Keyword:
PRE-MESSENGER-RNA
BCL-X
HNRNP A1
IN-VIVO
ANTISENSE OLIGONUCLEOTIDES
REGULATORY ELEMENTS
GENE-EXPRESSION
CELL-DEATH
PROTEINS
SELECTION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
32.1
论文数:
7.3K
被引数:
12.7W
机构
引用论文
Conserved reiterated domains in Clostridium thermocellum endoglucanases are not essential for catalytic activity
Gene
IF0
Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo
NUCLEIC ACIDS RESEARCH
IF13.1
Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing
MOLECULAR CELL
IF16.6

